Latest Articles

Publication Date
Merck's endometrial cancer drug meets late-stage trial goals - AOL.com

Merck's endometrial cancer drug meets late-stage trial goals AOL.com

Published: May 24, 2026, 8:39 p.m.
Mali Barbi: Groundbreaking ASCO26 Results Revealing Potential Cure in Advanced Endometrial Cancer - Oncodaily

Mali Barbi: Groundbreaking ASCO26 Results Revealing Potential Cure in Advanced Endometrial Cancer Oncodaily

Published: May 24, 2026, 1:05 p.m.
Merck Announces Positive Phase 3 Results for Endometrial Cancer Drug - HarianBasis.co

Merck Announces Positive Phase 3 Results for Endometrial Cancer Drug HarianBasis.co

Published: May 23, 2026, 1:10 p.m.
Merck (MRK) Phase 3 TroFuse-005 Trial for Endometrial Cancer Meets Primary Endpoints - Yahoo Finance

Merck (MRK) Phase 3 TroFuse-005 Trial for Endometrial Cancer Meets Primary Endpoints Yahoo Finance

Published: May 23, 2026, 12:01 p.m.
Decidualization potential of endometrial mesenchymal stem cells and their role in reproductive health.

The establishment of a successful pregnancy depends on proper embryo development and coordinated endometrial differentiation, particularly through the process of decidualization. Mesenchymal stem/stromal cells (MSCs), especially those derived from endometrial …

Published: May 23, 2026, midnight
Lesion-centric reprogramming: hydrogel-enabled photothermal reset of endometriosis pain.

Endometriosis-associated pelvic pain represents a prototypical failure of systemic therapy for a locally organized, neuroinflammatory disease. Persistent pain arises from the convergence of estrogen-driven lesion survival, chronic inflammation, fibrosis, and …

Published: May 23, 2026, midnight
Endometrial Serous Carcinoma Arising From Adenomyosis - Cureus

Endometrial Serous Carcinoma Arising From Adenomyosis Cureus

Published: May 22, 2026, 4:43 p.m.
Advances in Molecular Profiling and GLP-1 Therapy Offer Hope in Endometrial Cancer - Pharmacy Times

Advances in Molecular Profiling and GLP-1 Therapy Offer Hope in Endometrial Cancer Pharmacy Times

Published: May 22, 2026, 4:14 p.m.
Can GLP-1 Receptor Agonists Improve Outcomes in Patients at Risk for Endometrial Cancer? - Pharmacy Times

Can GLP-1 Receptor Agonists Improve Outcomes in Patients at Risk for Endometrial Cancer? Pharmacy Times

Published: May 22, 2026, 4:29 a.m.
Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer, Full Data Due at ASCO 2026 - OncLive

Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer, Full Data Due at ASCO 2026 OncLive

Published: May 22, 2026, 3:43 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!